Search

Extended use of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg: A population pharmacokinetic approach to estimate in vivo levonorgestrel release rates and systemic exposure including comparison with two other LNG-IUSs.

Therapeutic area :

Jensen J.T., Reinecke I., Post T.M. , Lukkari-Lax E. , Hofmann B.M,

Extended use of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg: A population pharmacokinetic approach to estimate in vivo levonorgestrel release rates and systemic exposure including comparison with two other LNG-IUSs. Contraception, 2023. [Link to publication].

Our expertise

Anesthesiology Endocrinology/Sexual health Pain General modelling Oncology CNS Biologicals Gastrointestinal Diseases Methods Lung Diseases Cardiovascular Paediatrics Diabetes Anti-infectives and immunology Blood disorders Peripheral Nervous System Safety pharmacology